Jan 09, 2015 8:30am EST SCYNEXIS, Inc. Receives FDA Fast Track Designation for Oral Formulation of SCY-078 for the Treatment of Patients With Invasive Fungal Infections
Dec 03, 2014 8:30am EST SCYNEXIS, Inc. Announces Appointment of Two Seasoned Industry Professionals to Its Board of Directors